FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Actonel (risendronate sodium) filed by Allergan, Inc., to update the labeling related to its approved uses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Osteoporosis
• Paget Disease of Bone
• Postmenopausal Osteoporosis

Drugs mentioned

• Actonel (risedronate)

Snippet

SUPPL AP for ACTONEL (RISEDRONATE SODIUM)